Add on Lacosamide Versus High Dose Monotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 1, 2011

Primary Completion Date

February 15, 2014

Study Completion Date

October 21, 2014

Conditions
Epilepsy
Interventions
DRUG

lacosamide

"Lacosamide maximum of 200 mg/day, to be titrated as follows:~* Week 1: 50 mg twice a day~* Beginning Week 2: 100 mg twice a day."

DRUG

levetiracetam

Low dose ≤1500 mg/day, High dose \>1500 mg/day

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT01345058 - Add on Lacosamide Versus High Dose Monotherapy | Biotech Hunter | Biotech Hunter